Optima Medical Innovations Pattern Recognition Three Stars In The South

TOKIFDelisted Stock  USD 0.0001  0.00  0.00%   
This pattern recognition tool runs Three Stars In The South recognition and companion studies for Optima Medical. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Recognition
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Optima Medical Technical Analysis Modules

Most technical analysis of Optima Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Optima from various momentum indicators to cycle indicators. When you analyze Optima charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Optima Medical Innovations

Optima Medical Innovations Corp. produces and sells hemp-based cannabidiol products in Canada and internationally. Optima Medical Innovations Corp. is based in Toronto, Canada. Optima Med is traded on OTC Exchange in the United States. Liquidity and trading activity can influence how quickly new information is reflected in Optima Medical's price. Lower liquidity may increase execution variability. Optima Medical has a market cap of 1.78 M, ROE of -10.39%.

Methodology

Unless otherwise specified, financial data for Optima Medical Innovations is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Optima (USA Stocks:TOKIF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We rely on public filings and market reference sources and disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR as reference sources. Some values may reflect delayed dissemination. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Optima Medical Innovations may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.


Become your own money manager

Tracking Optima Medical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
FinTech Idea
FinTech
Invested over 60 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Advertising Idea
Advertising
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Impulse Idea
Impulse
Invested over 200 shares
Blockchain Idea
Blockchain
Invested few shares
Video Games Idea
Video Games
Invested few shares
Marketing Idea
Marketing
Invested few shares
Optima Medical has a market cap of 1.78 M, operating margin of 9.29%, ROE of -10.39%. Review World Market Map for broader portfolio context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Analysis related to Optima Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Optima Pink Sheet

OTC-traded securities such as Optima Medical require careful evaluation of reporting standards.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance